Atlas Trials

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Clinical trial NCT02782182 · TERMINATED

Trial details

NCT number
NCT02782182
Sponsor
University of Chicago
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Ductal Adenocarcinoma (PDAC)
Start date
2016-06-28
Primary completion
2018-03-29
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.